WACKER CHEMIE AG (WCH.DE) Fundamental Analysis & Valuation

FRA:WCH • DE000WCH8881

Current stock price

87.925 EUR
-0.58 (-0.65%)
Last:

This WCH.DE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. WCH.DE Profitability Analysis

1.1 Basic Checks

  • In the past year WCH has reported negative net income.
  • In the past year WCH had a positive cash flow from operations.
  • Of the past 5 years WCH 4 years were profitable.
  • Each year in the past 5 years WCH had a positive operating cash flow.
WCH.DE Yearly Net Income VS EBIT VS OCF VS FCFWCH.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 500M -500M 1B

1.2 Ratios

  • WCH has a worse Return On Assets (-10.93%) than 79.71% of its industry peers.
  • The Return On Equity of WCH (-25.42%) is worse than 85.51% of its industry peers.
Industry RankSector Rank
ROA -10.93%
ROE -25.42%
ROIC N/A
ROA(3y)-1.24%
ROA(5y)3.9%
ROE(3y)-3.52%
ROE(5y)8.38%
ROIC(3y)N/A
ROIC(5y)N/A
WCH.DE Yearly ROA, ROE, ROICWCH.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20

1.3 Margins

  • WCH's Operating Margin has declined in the last couple of years.
  • The Gross Margin of WCH (12.08%) is worse than 78.26% of its industry peers.
  • In the last couple of years the Gross Margin of WCH has declined.
  • The Profit Margin and Operating Margin are not available for WCH so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 12.08%
OM growth 3Y-66.98%
OM growth 5Y-40.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.7%
GM growth 5Y-5.97%
WCH.DE Yearly Profit, Operating, Gross MarginsWCH.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 20

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. WCH.DE Health Analysis

2.1 Basic Checks

  • WCH does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • WCH has about the same amout of shares outstanding than it did 1 year ago.
  • Compared to 5 years ago, WCH has about the same amount of shares outstanding.
  • The debt/assets ratio for WCH is higher compared to a year ago.
WCH.DE Yearly Shares OutstandingWCH.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M
WCH.DE Yearly Total Debt VS Total AssetsWCH.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B

2.2 Solvency

  • WCH has an Altman-Z score of 2.39. This is not the best score and indicates that WCH is in the grey zone with still only limited risk for bankruptcy at the moment.
  • WCH has a Altman-Z score of 2.39. This is comparable to the rest of the industry: WCH outperforms 55.07% of its industry peers.
  • A Debt/Equity ratio of 0.61 indicates that WCH is somewhat dependend on debt financing.
  • WCH has a Debt to Equity ratio of 0.61. This is in the lower half of the industry: WCH underperforms 62.32% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Altman-Z 2.39
ROIC/WACCN/A
WACC5.86%
WCH.DE Yearly LT Debt VS Equity VS FCFWCH.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 1B 2B 3B 4B

2.3 Liquidity

  • WCH has a Current Ratio of 3.06. This indicates that WCH is financially healthy and has no problem in meeting its short term obligations.
  • The Current ratio of WCH (3.06) is better than 84.06% of its industry peers.
  • A Quick Ratio of 1.93 indicates that WCH should not have too much problems paying its short term obligations.
  • The Quick ratio of WCH (1.93) is better than 82.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.06
Quick Ratio 1.93
WCH.DE Yearly Current Assets VS Current LiabilitesWCH.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B 4B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

3

3. WCH.DE Growth Analysis

3.1 Past

  • The earnings per share for WCH have decreased strongly by -483.88% in the last year.
  • The Revenue has decreased by -3.90% in the past year.
  • Measured over the past years, WCH shows a small growth in Revenue. The Revenue has been growing by 3.17% on average per year.
EPS 1Y (TTM)-483.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.51%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y-12.58%
Revenue growth 5Y3.17%
Sales Q2Q%-6.07%

3.2 Future

  • The Earnings Per Share is expected to grow by 18.76% on average over the next years. This is quite good.
  • Based on estimates for the next years, WCH will show a small growth in Revenue. The Revenue will grow by 3.29% on average per year.
EPS Next Y102.46%
EPS Next 2Y45.69%
EPS Next 3Y28.95%
EPS Next 5Y18.76%
Revenue Next Year0.63%
Revenue Next 2Y2.85%
Revenue Next 3Y2.79%
Revenue Next 5Y3.29%

3.3 Evolution

  • The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
WCH.DE Yearly Revenue VS EstimatesWCH.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 2B 4B 6B 8B
WCH.DE Yearly EPS VS EstimatesWCH.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0 10 -10 20

More info and screens

Find the best growth stocksShow best growing peers

1

4. WCH.DE Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for WCH. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 192.36 indicates a quite expensive valuation of WCH.
  • 72.46% of the companies in the same industry are cheaper than WCH, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of WCH to the average of the S&P500 Index (23.69), we can say WCH is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 192.36
WCH.DE Price Earnings VS Forward Price EarningsWCH.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 50 100 150

4.2 Price Multiples

  • The rest of the industry has a similar Enterprise Value to EBITDA ratio as WCH.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.46
WCH.DE Per share dataWCH.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
  • A more expensive valuation may be justified as WCH's earnings are expected to grow with 28.95% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y45.69%
EPS Next 3Y28.95%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. WCH.DE Dividend Analysis

5.1 Amount

  • WCH does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

WCH.DE Fundamentals: All Metrics, Ratios and Statistics

WACKER CHEMIE AG

FRA:WCH (4/9/2026, 11:24:30 AM)

87.925

-0.58 (-0.65%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)03-11
Earnings (Next)04-29
Inst Owners10.77%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap4.59B
Revenue(TTM)8.30B
Net Income(TTM)-915.10M
Analysts66.09
Price Target73.98 (-15.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly Dividend2.5
Dividend Growth(5Y)38.02%
DP-13.57%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-649.33%
Min EPS beat(2)-1153.62%
Max EPS beat(2)-145.05%
EPS beat(4)0
Avg EPS beat(4)-424.02%
Min EPS beat(4)-1153.62%
Max EPS beat(4)-145.05%
EPS beat(8)2
Avg EPS beat(8)-208.74%
EPS beat(12)4
Avg EPS beat(12)-140.92%
EPS beat(16)6
Avg EPS beat(16)-104.81%
Revenue beat(2)1
Avg Revenue beat(2)-0.08%
Min Revenue beat(2)-3.44%
Max Revenue beat(2)3.28%
Revenue beat(4)2
Avg Revenue beat(4)-0.13%
Min Revenue beat(4)-3.44%
Max Revenue beat(4)3.28%
Revenue beat(8)2
Avg Revenue beat(8)-0.95%
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)2.66%
PT rev (3m)5.71%
EPS NQ rev (1m)45.83%
EPS NQ rev (3m)-300%
EPS NY rev (1m)-30.31%
EPS NY rev (3m)-51.71%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0.38%
Revenue NY rev (3m)-0.81%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 192.36
P/S 0.55
P/FCF N/A
P/OCF 8.45
P/B 1.27
P/tB 1.36
EV/EBITDA 12.46
EPS(TTM)-18.58
EYN/A
EPS(NY)0.46
Fwd EY0.52%
FCF(TTM)-0.2
FCFYN/A
OCF(TTM)10.4
OCFY11.83%
SpS159.23
BVpS69.02
TBVpS64.46
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -10.93%
ROE -25.42%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 12.08%
FCFM N/A
ROA(3y)-1.24%
ROA(5y)3.9%
ROE(3y)-3.52%
ROE(5y)8.38%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)3.09%
ROCE(5y)9.46%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-66.98%
OM growth 5Y-40.19%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-19.7%
GM growth 5Y-5.97%
F-Score4
Asset Turnover0.99
Health
Industry RankSector Rank
Debt/Equity 0.61
Debt/FCF N/A
Debt/EBITDA 5.54
Cap/Depr 91.23%
Cap/Sales 6.66%
Interest Coverage N/A
Cash Conversion 136.16%
Profit Quality N/A
Current Ratio 3.06
Quick Ratio 1.93
Altman-Z 2.39
F-Score4
WACC5.86%
ROIC/WACCN/A
Cap/Depr(3y)127.28%
Cap/Depr(5y)120.18%
Cap/Sales(3y)10.49%
Cap/Sales(5y)8.7%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-483.88%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-676.51%
EPS Next Y102.46%
EPS Next 2Y45.69%
EPS Next 3Y28.95%
EPS Next 5Y18.76%
Revenue 1Y (TTM)-3.9%
Revenue growth 3Y-12.58%
Revenue growth 5Y3.17%
Sales Q2Q%-6.07%
Revenue Next Year0.63%
Revenue Next 2Y2.85%
Revenue Next 3Y2.79%
Revenue Next 5Y3.29%
EBIT growth 1Y-158.94%
EBIT growth 3Y-71.13%
EBIT growth 5Y-38.3%
EBIT Next Year909.87%
EBIT Next 3Y131.35%
EBIT Next 5Y75.76%
FCF growth 1Y96.89%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y74.81%
OCF growth 3Y-21.59%
OCF growth 5Y-9.09%

WACKER CHEMIE AG / WCH.DE Fundamental Analysis FAQ

What is the fundamental rating for WCH stock?

ChartMill assigns a fundamental rating of 3 / 10 to WCH.DE.


What is the valuation status for WCH stock?

ChartMill assigns a valuation rating of 1 / 10 to WACKER CHEMIE AG (WCH.DE). This can be considered as Overvalued.


What is the profitability of WCH stock?

WACKER CHEMIE AG (WCH.DE) has a profitability rating of 2 / 10.


How financially healthy is WACKER CHEMIE AG?

The financial health rating of WACKER CHEMIE AG (WCH.DE) is 4 / 10.